HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jason V Baker Selected Research
Jason V Baker Research Topics
Disease
26
Inflammation (Inflammations)
01/2021 - 08/2008
17
Acquired Immunodeficiency Syndrome (AIDS)
10/2020 - 04/2008
16
HIV Infections (HIV Infection)
01/2020 - 05/2009
13
Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 05/2009
6
Infections
01/2022 - 04/2007
5
COVID-19
01/2022 - 01/2020
3
Fibrosis (Cirrhosis)
01/2021 - 06/2011
3
Hypertension (High Blood Pressure)
01/2020 - 10/2011
3
Hepatitis C
10/2014 - 09/2009
3
Hepatitis B
07/2014 - 11/2006
3
Coinfection
07/2014 - 08/2013
3
Neoplasms (Cancer)
01/2014 - 04/2008
3
Liver Diseases (Liver Disease)
01/2014 - 04/2008
2
Pain (Aches)
06/2022 - 03/2022
2
Noncommunicable Diseases
10/2020 - 01/2018
2
Liver Cirrhosis (Hepatic Cirrhosis)
07/2017 - 08/2013
2
Diabetes Mellitus
05/2017 - 01/2014
2
Atherosclerosis
01/2017 - 06/2010
2
Obesity
10/2015 - 10/2014
2
Substance-Related Disorders (Drug Abuse)
10/2014 - 08/2013
2
Thrombosis (Thrombus)
11/2010 - 04/2007
1
Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1
Emphysema
01/2022
1
Lung Diseases (Lung Disease)
01/2022
1
Necrosis
10/2020
1
Hemorrhage
02/2020
1
Hypoalbuminemia
01/2018
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2017
1
Vitamin D Deficiency
01/2017
1
Vascular System Injuries
01/2017
1
Apnea
11/2015
1
Snoring
11/2015
1
Disorders of Excessive Somnolence (Hypersomnia)
11/2015
1
Insulin Resistance
10/2015
1
Hepatitis
01/2014
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2014
1
Vascular Diseases (Vascular Disease)
11/2013
1
Alcoholism (Alcohol Abuse)
08/2013
1
Alcohol-Related Disorders
08/2013
1
Viremia
08/2013
1
Myocardial Ischemia (Ischemic Heart Diseases)
03/2013
1
Thrombocytopenia (Thrombopenia)
01/2013
1
Bacterial Pneumonia
01/2013
Drug/Important Bio-Agent (IBA)
19
Biomarkers (Surrogate Marker)
IBA
01/2021 - 06/2010
12
Interleukin-6 (Interleukin 6)
IBA
01/2021 - 06/2010
12
C-Reactive Protein
IBA
01/2020 - 06/2010
12
RNA (Ribonucleic Acid)
IBA
01/2017 - 04/2008
11
fibrin fragment D (D-dimer)
IBA
02/2020 - 06/2010
7
Pharmaceutical Preparations
IBA
01/2022 - 09/2009
3
remdesivir
IBA
01/2022 - 01/2020
3
Lipids
IBA
10/2014 - 11/2011
2
Antiviral Agents (Antivirals)
IBA
01/2022 - 04/2021
2
Monoclonal Antibodies
IBA
01/2022 - 11/2021
2
bamlanivimab
IBA
01/2022 - 11/2021
2
Vaccines
IBA
01/2022 - 04/2021
2
Angiotensin Receptor Antagonists
IBA
01/2022 - 01/2021
2
Serum Albumin
IBA
01/2018 - 01/2014
2
Hemoglobins (Hemoglobin)
IBA
07/2017 - 01/2014
2
Lipopolysaccharide Receptors
IBA
10/2015 - 11/2014
2
Cholesterol
IBA
01/2014 - 01/2014
2
Hyaluronic Acid (Hyaluronan)
IBA
01/2014 - 06/2011
2
LDL Cholesterol
IBA
01/2014 - 10/2011
2
HDL Cholesterol
IBA
01/2014 - 09/2009
2
Cystatin C
IBA
01/2014 - 06/2010
2
HDL Lipoproteins
IBA
11/2011 - 11/2010
2
Lipoproteins (Lipoprotein)
IBA
04/2011 - 11/2010
1
Antigens
IBA
01/2022
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2021
1
Losartan (Cozaar)
FDA Link
Generic
01/2021
1
pro-brain natriuretic peptide (1-76)
IBA
10/2020
1
Factor Xa Inhibitors
IBA
02/2020
1
edoxaban
IBA
02/2020
1
Factor Xa (Coagulation Factor Xa)
IBA
02/2020
1
Investigational Drugs
IBA
01/2020
1
Lactoferrin
IBA
01/2019
1
Serum Amyloid A Protein (Serum Amyloid A)
IBA
01/2019
1
Thrombin
FDA Link
10/2018
1
Anticoagulants
IBA
10/2018
1
Immunosorbents
IBA
01/2017
1
Enzymes
IBA
01/2017
1
Vitamin D
FDA Link
Generic
01/2017
1
Leptin
IBA
10/2015
1
Zidovudine (Retrovir)
FDA Link
Generic
07/2014
1
Triglycerides (Triacylglycerol)
IBA
01/2014
1
Blood Coagulation Factors (Coagulation Factor)
IBA
11/2013
1
Ethanol (Ethyl Alcohol)
IBA
08/2013
1
Thromboplastin (Tissue Factor)
IBA
07/2013
1
Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)
IBA
01/2013
1
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
06/2012
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2012
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2012
1
Apolipoprotein A-I (Apolipoprotein A1)
IBA
11/2011
Therapy/Procedure
29
Therapeutics
06/2022 - 11/2006
13
Art Therapy
10/2020 - 05/2009
2
Highly Active Antiretroviral Therapy (HAART)
01/2014 - 04/2008
1
Massage (Zone Therapy)
03/2022
1
Physical Therapy Modalities (Physical Therapy Technique)
03/2022
1
Meditation
03/2022
1
Oral Administration
01/2019
1
Stem Cell Transplantation
11/2017